GlobeNewsWire
17 Jul 2026, 10:36 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Insulet disclosed manufacturing defects in Omnipod 5, DASH, and Eros systems involving tubing tears that could cause insulin under-delivery. — Product safety failures in medical devices pose severe regulatory risks and threaten the core revenue stream of the company's primary platform.
-0.80A securities fraud class action lawsuit has been filed against Insulet and its executives alleging misrepresentations regarding product safety and manufacturing capabilities. — Legal action for securities fraud creates potential for significant financial settlements and damages investor confidence in corporate governance.
-0.50Insulet issued two separate voluntary Medical Device Corrections in March and May 2026 following the discovery of manufacturing issues. — Repeated recalls indicate systemic quality control issues rather than an isolated incident, increasing the likelihood of intensified regulatory scrutiny.
-0.40Continue reading
6 related stories
Top 1 mover · tap to explore
Which stocks this story touches
Facing a securities fraud class action lawsuit following manufacturing defects and significant stock price drops.
Mentioned only in the context of a past legal recovery by the law firm.
Mentioned only in the context of a past legal recovery by the law firm.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
2h ago
